Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
- 3 Habosem Street
- Ashdod , 77610
Procognia (Israel) Ltd. is a world leader in glycobiology, with an exclusive range of proprietary technologies and applications covering four key platforms: analytics, diagnostics, therapeutic antibodies and stem cells.